Have questions? Connect with us for answers to questions about and assistance with:
AMAG Pharmaceuticals is a biopharmaceutical company focused on bringing therapeutics to market that provide clear benefits and help improve people's lives. For more information about other AMAG Pharmaceuticals products and services, please contact Medical Affairs at 1-877-411-2510, Monday−Friday, 9 AM - 5 PM (ET).
1100 Winter Street
Waltham, MA 02451
Prime Therapeutics Specialty Pharmacy LLC (Prime Specialty Pharmacy) is a wholly-owned subsidiary of Prime Therapeutics LLC.
Makena (hydroxyprogesterone caproate injection) is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. The effectiveness of Makena is based on improvement in the proportion of women who delivered <37 weeks of gestation. There are no controlled trials demonstrating a direct clinical benefit, such as improvement in neonatal mortality and morbidity.
Limitation of use: While there are many risk factors for preterm birth, safety and efficacy of Makena has been demonstrated only in women with a prior spontaneous singleton preterm birth. It is not intended for use in women with multiple gestations or other risk factors for preterm birth.
Please see full Prescribing Information for Makena.